(Q42253345)

19 October 2017

title

Delirium with phenytoin and disulfiram administration (English)

1 reference

19 October 2017

1 reference

1 reference

Brown CG

1

1 reference

19 October 2017

Kaminsky MJ

series ordinal

2

1 reference

19 October 2017

Feroli ER Jr

series ordinal

3

1 reference

19 October 2017

Gurley HT

series ordinal

4

1 reference

19 October 2017

language of work or name

English

0 references

publication date

1 May 1983

1 reference

Annals of Emergency Medicine

19 October 2017

published in

1 reference

19 October 2017

volume

12

1 reference

19 October 2017

issue

5

1 reference

19 October 2017

page(s)

310-313

1 reference

Delirium and dementia: diagnostic criteria and fatality rates

19 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Delirium, a syndrome of cerebral insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Acute organic brain syndrome: A review of 100 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Subacute combined degeneration of the spinal cord; current concepts of the disease process; value of serum vitamin B12; determinations in clarifying some of the common clinical problems

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Cerebral manifestations of vitamin-B12 deficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

DIPHENYLHYDANTOIN METABOLISM, BLOOD LEVELS, AND TOXICITY.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Biochemical and genetic factors regulating dilantin metabolism in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Plasma Albumin Concentration and Diphenylhydantoin Binding in Man

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Antiepileptic Drugs: Biotransformation, Metabolism, and Serum Half-Life

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Effect of dosage increments on blood phenytoin concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Influence of disease on binding of drugs to plasma proteins

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Protein binding of diphenylhydantoin and desmethylimipramine in plasma from patients with poor renal function.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Interactions of Antiepileptic Drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Disulfiramum (antabuse) as inhibitor of phenytoin metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Phenytoin intoxication during treatment with antabuse (Disulfiram)

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

The influence of disulfiram and calcium carbimide on the serum diphenylhydantoin. Excretion of HPPH in the urine

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

The influence of disulfiram on the half life and metabolic clearance rate of diphenylhydantoin and tolbtamide in man

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Psychotic reactions during tetraethylthiuramdisulfide (antabuse) therapy.

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Disulfiram (Antabuse) Psychosis

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

Disulfiram-Induced Encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0196-0644%2883%2980516-2

7 January 2021

10.1016/S0196-0644(83)80516-2

Identifiers

DOI

1 reference

19 October 2017

1 reference